BiQ: Quick Market Update for May 20, 2025 (XBI)

It's been a great few days for biotech, with the XBI posting four consecutive green candles. I am hoping the XBI can fill the gap to around the 84 level, which would be a bullish signal to me, but it's not something I am betting on yet.

The XBI now sits right at the descending trendline, and the RSI is approaching levels where we have seen reversals in the recent past. I remain cautious in this market, continuing to maintain above-average liquidity and selling covered calls aggressively.

Also, tomorrow is a big day for Urogen (URGN) as the ODAC will debate the merits of UGN-102. For those who may have missed my recent article, it can be found here.

Good luck to everyone, stick to your trading plan, and stay safe.

Not a BiQ Premium member, or have a friend who may be interested? Try BiQ Premium for $10 (80% off) for the first month, or $250 (50% off) for the first year.

Biotech iQ is 100% subscriber supported. If you find this information helpful, please spread the word. You can also follow me on X @ Biotech iQ (_Biotech_iQ).

Biotech iQ is not an investment professional, and nothing on this page or this website should be considered investment advice. Please consult with a licensed investment professional as necessary. Past performance is not indicative of future results.